Article Versions Notes

Scherf-Clavel M, Fekete S, Gerlach M, Correll CU, Plener P, Fegert JM, Karwautz A, Heuschmann P, Banaschewski T, Briegel W, et al. Sex-Specific Differences in Antidepressant and Antipsychotic Treatment Outcomes and Serum Levels in Children and Adolescents. Pharmaceutics. 2025; 17(8):983. https://doi.org/10.3390/pharmaceutics17080983

Scherf-Clavel, Maike, Stefanie Fekete, Manfred Gerlach, Christoph U. Correll, Paul Plener, Jörg M. Fegert, Andreas Karwautz, Peter Heuschmann, Tobias Banaschewski, Wolfgang Briegel, and et al. 2025. "Sex-Specific Differences in Antidepressant and Antipsychotic Treatment Outcomes and Serum Levels in Children and Adolescents" Pharmaceutics 17, no. 8: 983. https://doi.org/10.3390/pharmaceutics17080983

Scherf-Clavel, M., Fekete, S., Gerlach, M., Correll, C. U., Plener, P., Fegert, J. M., Karwautz, A., Heuschmann, P., Banaschewski, T., Briegel, W., Fleischhaker, C., Hellenschmidt, T., Imgart, H., Kaess, M., Kölch, M., Reitzle, K., Renner, T. J., Rexroth, C., Schulte-Körne, G., ... Taurines, R. (2025). Sex-Specific Differences in Antidepressant and Antipsychotic Treatment Outcomes and Serum Levels in Children and Adolescents. Pharmaceutics, 17(8), 983. https://doi.org/10.3390/pharmaceutics17080983